In addition, rearrangements or mutations of NF-κB2 leading to sequential non-canonical activation of NF-κB have also been found in various human malignancies, including multiple myeloma, and T-cell and B-cell lymphoma [91,92]. The gene discussed is NFKB1; the disease is AL amyloidosis.